Clinical trials
Phase 3 COVID-19 trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 10 |
| 2023 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 5 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Murdoch Childrens Research Institute | 4 |
| Novavax | 2 |
| University of Minnesota | 2 |
| Vaxine Pty Ltd | 2 |
| Ansun Biopharma, Inc. | 1 |
| Arcturus Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| BioNTech SE | 1 |
| Dompé Farmaceutici S.p.A | 1 |
| Kirby Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 23 |
| Coronavirus Infections | 7 |
| Influenza, Human | 3 |
| Lung Diseases | 2 |
| Respiratory Tract Infections | 2 |
| Community-Acquired Pneumonia | 1 |
| Infections | 1 |
| Lymphoma, Follicular | 1 |
| Neoplasms | 1 |
| Neurologic Manifestations | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.